Insulet (PODD)

• Market cap: $10.4B
• 1 day: 0.34%
• 5 days: -1.5%
• 1 month: -5.46%
• 3 months: -36.59%
• 6 months: -49.37%
• Year to date: -47.09%
• 1 year: -50.69%
• 5 years: -47.28%
• 10 years: 386.51%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 5,400